Term ends Sep 20, 2038 · High confidence
20-year base term ends Sep 20, 2038
Held by Nacuity Pharmaceuticals, Inc.
Filed Jan 9, 2023 as application 18/094,459 · Granted Jun 23, 2026
Base term plus 349 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
2018
2038
Clock starts
Sep 20, 2018
Sep 20, 2018
Term ends
Sep 20, 2038
Sep 20, 2038
Granted
Jun 23, 2026
Jun 23, 2026
base term
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
349
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 10,590,073, US 11,091,433, US 11,548,851.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
22
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 349 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Sep 20, 2018, when application 16/137,262, the earliest non-provisional in its chain, was filed (this one was filed Jan 9, 2023) | Sep 20, 2038 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +349 days, USPTO patent term adjustment record | Sep 4, 2039 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,590,073, US 11,091,433, US 11,548,851) | capped to Sep 20, 2038 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Sep 20, 2038 | High confidence |
This family
| Application 62/561,129 | Provisional application no patent term | no patent term |
| US 10,590,073 | In force Sep 2038 | Sep 2038 |
| US 11,670,768 | In force Jun 2039 | Jun 2039 |
| US 11,091,433 | In force Sep 2038 | Sep 2038 |
| US 11,548,851 | In force Sep 2038 | Sep 2038 |
| US 12,662,449 | this patent Sep 2038 | Sep 2038 |
| US 12,068,480 | In force Jun 2039 | Jun 2039 |
| Application 18/687,550 | Pending not computed | not computed |
8 of 22 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 20, 2023 Reel 62743, frame 178 | Wall, G. Michael; Johnson, Doug; Rubenstein, Anja; Tucker, Rodney; Bolger, Josh | Nacuity Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Apr 4, 2023 Reel 63213, frame 272 | Sheehan, Craig; Kowalczyk, Marcin Jakub | Nacuity Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Sep 2038
Term ends Sep 20, 2038. Maintenance fees still fall due before then
Note
The 349 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 10,590,073, US 11,091,433, US 11,548,851.
Citations
We have no citation count for this patent yet. That is not the same as never having been cited.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.